BEIJING, Oct 16 (Reuters) - China’s drug regulator imposed penalties on a unit of Changsheng Bio-Technology worth 9.1 billion yuan ($1.3 billion) over a vaccine scandal, Xinhua news agency said on Tuesday.
The penalties involved a fine and the confiscation of illegal earnings. The drug authority also banned 14 executives of Changsheng Bio-Technology from working in the drug business, Xinhua reported.
The company was accused in July of falsifying data for a rabies vaccine and manufacturing an ineffective vaccine for babies, sparking widespread consumer anger.
$1 = 6.9172 Chinese yuan renminbi Reporting by Beijing Monitoring Desk Editing by Edmund Blair